-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$5.75-43.57% Downside
Thorne HealthTech, Inc. Frequently Asked Questions
-
What analysts cover Thorne HealthTech, Inc.?
Thorne HealthTech, Inc. has been rated by research analysts at Canaccord Genuity, RBC Capital in the past 90 days.